Hepatitis C virus hijacks host lipid metabolism

Area of Science:

• Virology
• Hepatology
• Molecular Biology

Background:

• Hepatitis C virus (HCV) infection is a global health concern, leading to chronic liver disease.
• HCV replication and pathogenesis are intricately linked to host cell lipid metabolism.
• HCV circulates in the bloodstream associated with lipoproteins, suggesting a role for lipids in its lifecycle.

Purpose of the Study:

• To review how HCV manipulates host lipid metabolism to enhance viral replication.
• To elucidate the role of lipid homeostasis and very low-density lipoprotein (VLDL) pathways in HCV infection.
• To highlight how HCV-induced metabolic alterations contribute to liver disease progression.

Main Methods:

• This review synthesizes findings from existing literature on HCV and lipid metabolism.
• Analysis of studies investigating the impact of HCV on lipogenesis, lipid secretion, and beta-oxidation.
• Examination of research on the interplay between VLDL assembly components and HCV morphogenesis/secretion.

Main Results:

• HCV infection promotes lipogenesis and impairs lipid secretion and beta-oxidation, leading to hepatic steatosis.
• Lipids are essential for multiple stages of the HCV life cycle, including replication, maturation, and secretion.
• HCV negatively modulates VLDL synthesis and secretion, co-opting the VLDL pathway for its own release.

Conclusions:

• HCV extensively alters host lipid metabolism to support its replication and propagation.
• The virus exploits the VLDL secretory pathway for efficient assembly and release.
• Understanding these metabolic adaptations is crucial for developing novel therapeutic strategies against HCV and associated liver disease.